Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study

Renate B. Schnabel; Josée Dupuis; Martin G. Larson; Kathryn L. Lunetta; Sander J. Robins; Yanyan Zhu; Jian Rong; Xiaoyan Yin; Heide A. Stirnadel; Jeanne J. Nelson; Peter W.F. Wilson; John F. Keaney; Ramachandran S. Vasan; Emelia Benjamin

doi:10.1016/j.atherosclerosis.2008.10.030

Back

Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study

Article 2008 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2012

Lipoprotein Phospholipase A2 and Cerebral Microbleeds in the Framingham Heart Study

José R. Romero, Sarah R. Preis, Alexa S. Beiser, Charles DeCarli, Dong Young Lee, Anand Viswanathan, Emelia Benjamin, João D. Fontes, Rhoda Au, Aleksandra Pikula, Jimmy Wang, Carlos S. Kase, Philip A. Wolf, Michael C. Irrizary, Sudha Seshadri

Article2015

Elevated circulating levels of lipoprotein-associated phospholipase A2 in obese children

Sophia Sakka, Tania Siahanidou, Chronis Voyatzis, Panagiota Pervanidou, Christina Kaminioti, Natalia Lazopoulou, Christina Kanaka‐Gantenbein, George Chrousos, Ioannis Papassotiriou

Article2010

Lipoprotein-Associated Phospholipase A2 Activity and Incident Coronary Heart Disease Among Men and Women With Type 2 Diabetes

Ida J. Hatoum, Frank B Hu, Jeanenne J. Nelson, Eric B. Rimm

Article2010

Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease

Ida J. Hatoum, Jeanenne J. Nelson, Nancy R. Cook, Frank B Hu, Eric B. Rimm

Article2025

Association of Lipoprotein(a) With Atrial Fibrillation in the Framingham Heart Study

Celestin Hategeka, Emelia Benjamin, Sarah R. Preis